Abivax (ABVX) Revenue (2024 - 2026)
Powered by 
Analysis
Abivax (ABVX) Revenue (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Abivax | 6.50 Bn | 4.15 Bn | - | 52.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.70 Mn |
| Dec 31, 2025 | -247.98 Mn |
| Sep 30, 2025 | 112.71 Mn |
| Jun 30, 2025 | 6.31 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 926,472.21 |
| Sep 30, 2024 | 11.48 Mn |
| Jun 30, 2024 | 10.05 Mn |
| Mar 31, 2024 | 7.35 Mn |
API Access
Abivax Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();